Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNL
2776
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $388K | ﹤0.01% |
7,283
+3,150
| +76% | +$170K |
|
|
MINI
2777
DELISTED
Mobile Mini Inc
MINI
| $387K | ﹤0.01% |
+12,559
| New | +$444K |
|
|
RPXC
2778
DELISTED
RPX Corporation
RPXC
| $387K | ﹤0.01% |
28,174
-90,933
| -76% | -$1.35M |
|
|
CCC
2779
DELISTED
Calgon Carbon Corp
CCC
| $387K | ﹤0.01% |
24,830
-315,949
| -93% | -$5.28M |
|
2780
iShares US Basic Materials ETF
IYM
$1.04B
| $386K | ﹤0.01% |
+5,956
| New | +$432K |
|
|
WIN
2781
DELISTED
Windstream Holdings Inc
WIN
| $386K | ﹤0.01% |
12,582
-358,483
| -97% | -$11.2M |
|
|
TBRA
2782
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $385K | ﹤0.01% |
39,831
+4,740
| +14% | +$66.5K |
|
2783
Chubb
CB
$132B
| $383K | ﹤0.01% |
3,701
-157,743
| -98% | -$16.5M |
|
|
GARS
2784
DELISTED
Garrison Capital Inc.
GARS
| $383K | ﹤0.01% |
27,989
+1,781
| +7% | +$26.2K |
|
2785
Barings BDC
BBDC
$982M
| $382K | ﹤0.01% |
+23,186
| New | +$468K |
|
2786
vTv Therapeutics
VTVT
$135M
| $382K | ﹤0.01% |
+1,466
| New | +$511K |
|
|
TRK
2787
DELISTED
Speedway Motorsports, Inc.
TRK
| $381K | ﹤0.01% |
21,115
+7,041
| +50% | +$143K |
|
2788
Las Vegas Sands
LVS
$30.5B
| $380K | ﹤0.01% |
10,000
+4,955
| +98% | +$250K |
|
|
WINT
2789
DELISTED
Windtree Therapeutics Inc
WINT
| $378K | ﹤0.01% |
89,923
+16,595
| +23% | +$110K |
|
2790
Invesco S&P Spin-Off ETF
CSD
$224M
| $377K | ﹤0.01% |
+9,894
| New | +$424K |
|
2791
Silgan Holdings
SLGN
$4.49B
| $377K | ﹤0.01% |
14,502
-14,530
| -50% | -$384K |
|
2792
Ulta Beauty
ULTA
$22.8B
| $376K | ﹤0.01% |
2,301
-211,206
| -99% | -$34.8M |
|
|
UIL
2793
DELISTED
UIL HOLDINGS
UIL
| $376K | ﹤0.01% |
7,479
-93
| -1% | -$4.4K |
|
2794
British American Tobacco
BTI
$121B
| $374K | ﹤0.01% |
+6,804
| New | +$378K |
|
2795
Fortuna Silver Mines
FSM
$3.64B
| $374K | ﹤0.01% |
171,542
-64,102
| -27% | -$171K |
|
2796
Daily Journal
DJCO
$830M
| $372K | ﹤0.01% |
+2,000
| New | +$398K |
|
|
SQBG
2797
DELISTED
Sequential Brands Group, Inc.
SQBG
| $372K | ﹤0.01% |
+643
| New | +$421K |
|
2798
ProShares Ultra Dow30
DDM
$585M
| $371K | ﹤0.01% |
+39,726
| New | +$412K |
|
2799
Cleveland-Cliffs
CLF
$6.53B
| $370K | ﹤0.01% |
+151,599
| New | +$484K |
|
|
ALIM
2800
DELISTED
Alimera Sciences
ALIM
| $369K | ﹤0.01% |
11,135
-8,471
| -43% | -$477K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.